 In adult patients taking valproate alone, 30–50% of an administered dose is excreted in urine as a glucuronide conjugate.The other major pathway in the metabolism of valproate is mitochondrial beta-oxidation, which typically accounts for over 40% of an administered dose.Typically, less than 20% of an administered dose is eliminated by other oxidative mechanisms.